About Alkuri Global Acquisition Corp
ARK Global Acquisition Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in Nashville, Tennessee. Address: 4235 Hillsboro Pike, Nashville, TN, United States, 37215
Alkuri Global Acquisition Corp News and around…
Latest news about Alkuri Global Acquisition Corp (KURIU) common stock and company :
Babylon today outlined its ongoing momentum, announcing a further c.135k lives will have access to its value-based care offering across the US and UK through its expansion to additional US states, Georgia and Mississippi, and further growth across California. This means that through a combination of its value-based care model, Babylon 360 and its work in primary care, Babylon will be managing c. 350k lives globally, including 105k NHS GP at Hand lives, by the start of 2022. Babylon reiterated 20
Babylon Holdings Limited ("Babylon"), one of the world's fastest-growing digital healthcare companies, today announced that it has secured a sustainability-linked investment of up to $200 million from Albacore Capital Group ("AlbaCore"), a strategic capital investment firm.
Babylon today announced the appointment of US exchange veteran David Warren, who will join Babylon's board and serve as Chair of the Audit Committee when the company becomes publicly listed later this year.
The big shareholder groups in Alkuri Global Acquisition Corp. ( NASDAQ:KURI ) have power over the company. Institutions...
Babylon Holdings Limited ("Babylon"), a world leading company reengineering how people engage with their health at every step of the care continuum, today announced its financial and operating results for the six months ended June 30, 2021.
Researchers at Babylon, a leading digital-first value-based healthcare company, have found that members of Babylon's highly accessible, 24/7 primary care model incurred between 15-35% lower acute hospital costs than the regional average.
BALA CYNWYD, PA / ACCESSWIRE / June 17, 2021 / Brodsky & Smith reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions.If you own shares of any of the below-referenced stocks and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, wi
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Khosla Ventures Acquisition Co. (NASDAQ: KVSA) Kholsa Ventures has agreed to merge with Valo Hea
BALA CYNWYD, PA / ACCESSWIRE / June 4, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Alkuri Global Acquisition Corp. ("Alkuri Global" or the "Company") (NASDAQ:KURI) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which Alkuri Global, a special purpose acquisition company, will combine with Babylon Holdings Limited ("Babylon"), a wor
Dr Ali Parsa, founder of Babylon Health, is on track to become a billionaire as his business joins the Nasdaq.
Babylon Holdings Limited ("Babylon"), a world leading, digital-first value-based care company, and Alkuri Global Acquisition Corp. (NASDAQ:KURI) ("Alkuri Global"), a special purpose acquisition company, today announced that they have entered into a definitive merger agreement. Upon closing of the transaction, the combined company will operate as Babylon and plans to trade on Nasdaq under the new symbol "BBLN". The transaction reflects an initial pro forma equity value of approximately $4.2 billi
(Bloomberg) -- Babylon, the medical startup that connects patients and doctors via an app, is in talks to go public in a merger with blank-check company run by former Groupon Inc. executives, according to people familiar with the matter.The U.K.-based health-care group could reach an agreement with Alkuri Global Acquisition Corp. in the coming weeks, the people said, asking not to be identified discussing confidential information. Babylon could be valued at $3 billion to $4 billion in any deal, the people said.Alkuri is starting to raise an additional private investment in public equity pool of around $300 million to help fund a deal and already has support from several investors, one of the people said.Babylon has been working with advisers to explore a listing via a SPAC merger or traditional initial public offering over the last few months, Bloomberg News has previously reported. No final agreement has been reached and Babylon could opt for a different SPAC or seek an IPO, the people said.Representatives for Babylon and Nashville-based Alkuri declined to comment.Alkuri is led by Groupon’s ex-chief executive officer Rich Williams and former chief operating officer Steve Krenzer, who left those roles last year after turnaround plans for the online discount provider faltered. Prior to Groupon, Williams held senior roles at technology companies including Amazon.com Inc. Alkuri’s chairman is Sultan Almaadeed, a former executive at the Qatar Investment Authority.The SPAC listed in February and changed its name in March to Alkuri from Ark Global Acquisition Corp. after confusion with high-profile fund manager Cathie Wood’s firm, ARK Investment Management LLC. The blank-check company is focused on “next-generation technology businesses led by visionary founders and teams leveraging data and artificial intelligence in the areas of consumer internet and marketplaces, healthtech, fintech and mobility.”Failed TalksBabylon was founded in 2013. Its app lets users schedule a video chat with a doctor, check symptoms or book time with specialists, such as therapists. The U.K.’s National Health Service lets patients choose Babylon’s “GP at Hand” mobile consultation service as their official primary care provider. Babylon can be used to seek advice and treatment for conditions ranging from hair loss to chronic kidney disease, according to its website.The company previously explored a merger with a SPAC backed by financier Alec Gores before talks fell apart, the people said. The U.K. firm also attracted interest from Freedom Acquisition I Corp., the SPAC raised by former Credit Suisse Group AG CEO Tidjane Thiam, as well as a vehicle from Klaus Kleinfeld, the former head of Arconic, the people said.Representatives for Freedom, Gores and Kleinfeld declined to comment.A $550 million cash infusion led by Saudi Arabia’s Public Investment Fund in 2019 valued Babylon at about $2 billion. It put the company in a position to grow when the coronavirus pandemic hit last year, offering access to doctors from the safety of patients’ living rooms when many clinics were closed. It also gave people who suspected they had the virus a way to track their symptoms.“The pressure on us to go public, just because the public markets are flying right now, as you can imagine is significant,” Babylon CEO Ali Parsa said in an interview earlier this year.Company sales are expected increase fourfold and hit about $300 million in 2021, he said.(Adds details on other SPAC approaches under ‘Failed Talks’ subhead)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.